RESUMO
BACKGROUND: Dapsone (4,4'-diamino-diphenyl sulfone) is a synthetic derivative of sulfones, with the antimicrobial activity described since 1937. It is also a drug traditionally used in dermatological therapies due to its anti-inflammatory effect. In recent years its antioxidant, antiexcitotoxic, and antiapoptotic effects have been described in different ischemic damage models, traumatic damage, and models of neurodegenerative diseases, such as Parkinson's (PD) and Alzheimer's diseases (AD). Finally, dapsone has proven to be a safe and effective drug as a protector against heart, renal and pulmonary cells damage; that is why it is now employed in clinical trials with patients as a neuroprotective therapy by regulating the main mechanisms of damage that lead to cell death ObjectiveThe objective of this study is to provide a descriptive review of the evidence demonstrating the safety and therapeutic benefit of dapsone treatment, evaluated in animal studies and various human clinical trials Methods: We conducted a review of PubMed databases looking for scientific research in animals and humans, oriented to demonstrate the effect of dapsone on regulating and reducing the main mechanisms of damage that lead to cell death ConclusionThe evidence presented in this review shows that dapsone is a safe and effective neuro and cytoprotective treatment that should be considered for translational therapy.
Assuntos
Dapsona , Preparações Farmacêuticas , Animais , Antioxidantes , Apoptose , Dapsona/uso terapêutico , Humanos , NeuroproteçãoRESUMO
A series of novel (1S)-(-)-verbenone derivatives was synthesized bearing a 4-styryl scaffold. The synthesized compounds were tested for their anti-oxidant, anti-excitotoxic, and anti-ischemic activities. These derivatives significantly reduced oxygen-glucose deprivation-induced neuronal injury and N-methyl-D-aspartic acid-evoked excitotoxicity in cortical neurons. Furthermore, compound 3f was identified as a potent anti-ischemic agent in an in vitro ischemic model, potentially due to the inhibition of N-methyl-D-aspartic acid-evoked excitotoxicity and oxidative/nitrosative stress.
Assuntos
Antioxidantes , Descoberta de Drogas , Neurônios/efeitos dos fármacos , Terpenos/química , Animais , Antioxidantes/síntese química , Antioxidantes/química , Antioxidantes/farmacologia , Monoterpenos Bicíclicos , Células Cultivadas , Modelos Animais de Doenças , Isquemia/tratamento farmacológico , N-Metilaspartato/química , Fármacos Neuroprotetores/síntese química , Fármacos Neuroprotetores/química , Fármacos Neuroprotetores/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Terpenos/síntese química , Terpenos/farmacologiaRESUMO
Durante un proceso de lesión cerebral, por ejemplo en un traumatismo craneoencefálico, se activan respuestas que inducen daño cerebral o muerte celular; sin embargo, también se inducen respuestas de protección que intentan mantener la integridad y funcionalidad del cerebro; esto se conoce como neuroprotección. Efectivamente, posterior a un TCE, se desencadenan mecanismos que traen como consecuencia liberación de neurotransmisores excitadores tales como el glutamato, lo que provoca una entrada masiva de Ca²+ en las neuronas, activación de proteasas, lipasas, sintasa de óxido nítrico, endonucleasas, producción de radicales libres y potencialmente necrosis o apoptosis. Aunque hay reportes de sustancias neuro o cerebroprotectoras desde hace más de 50 años, es al final de la década de los ochenta del siglo pasado cuando comienza a aparecer un gran número de publicaciones tratando de entender los mecanismos neuroprotectores desencadenados por un insulto al cerebro. En este trabajo revisamos brevemente el concepto, la epidemiologia y los diversos agentes que se han utilizado para disminuir el daño causado por un traumatismo craneoencefálico.
During a process of brain injury, e.g. head injury, responses to induce brain damage and / or cell death are activated, but also protective responses that attempt to maintain the integrity and functionality of the brain are induced. This is known as neuroprotection. Indeed a head injury triggers mechanisms that result in release of excitatory neurotransmitters such as glutamate, which causes an influx of Ca²+ into neurons, activation of proteases, lipases, nitric oxide synthase, endonucleases, free radicals production and potentially necrosis and / or apoptosis. Although the brain or neuroprotective substances research has more than 50 years, is at the end of the decade of 80's of last century when it began to appear a large number of publications trying to understand the neuroprotective mechanisms triggered by an insult to the brain. In this paper we briefly review the concept, epidemiology and strategies that have been used to minimize the damage caused by brain injury.